Matthew Ricks, MD
Dermatology · Topeka, KSNPI 1669403861
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 83.7% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $2,817, 2.7 times the $1,033 reported in 2019. Among dermatology clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $45.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- Johnson & Johnson$236
- Genentech USA, Inc.$200
- Lilly USA, LLC$195
- Sun Pharmaceutical Industries Inc.$173
- Novartis$114
- plus $831 from 18 others
What the payments were for
- Consulting fees$1,0009%
- Speaking & faculty fees$6,34359%
- Food & beverage$3,27931%
- Education$801%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 131 | $8,953 |
| Johnson & Johnson | 12 | $236 |
| Genentech USA, Inc. | 11 | $200 |
| Lilly USA, LLC | 17 | $195 |
| Sun Pharmaceutical Industries Inc. | 11 | $173 |
| Novartis | 7 | $114 |
| Pfizer | 7 | $102 |
| Organogenesis Inc. | 5 | $94 |
| Prugen, Inc. Pharmaceuticals | 2 | $89 |
| Sanofi | 5 | $89 |
| LEO Pharma Inc. | 5 | $85 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $74 |
| Incyte Corporation | 2 | $43 |
| Mayne Pharma Commercial LLC | 2 | $38 |
| UCB, Inc. | 2 | $33 |
| Arcutis Biotherapeutics, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Bristol Myers Squibb | 2 | $28 |
| Galderma Laboratories, L.p. | 2 | $27 |
| VYNE Pharmaceuticals Inc. | 1 | $15 |
| Almirall LLC | 1 | $15 |
| Amgen | 1 | $14 |
| Dermira, Inc. | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erivedge$129
How this compares
$10,702 in reported general payments places this provider in the 90th percentile of 82 dermatology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 36 | $2,118 |
| Fluorouracil | 15 | $1,329 |
| Ketoconazole | 20 | $298 |
| Doxycycline Hyclate | 15 | $289 |
| Triamcinolone Acetonide | 26 | $272 |
| Doxycycline Monohydrate | 20 | $189 |
| Cephalexin | 48 | $73 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $35 |
| Clindamycin Hcl | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Topeka
- Michael KucenicTopeka$3K
- Karen StadlerTopeka$2K
- Robert DurstTopeka$1K
- Zachary BryanTopeka$744
- Coleman RitchieTopeka$694
- David KaplanOverland Park$489K
- Meena SinghOverland Park$181K
- Daniel AiresKansas City$83K
- Dominic WuShawnee Mission$51K
- Kyle AndersonLeawood$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.